Spirolactam bicyclic CGRP receptor antagonists

Details for Australian Patent Application No. 2006316646 (hide)

Owner Merck & Co., Inc.

Inventors Bell, Ian M.; Selnick, Harold G.; Stump, Craig A.; Zartman, C. Blair; Theberge, Cory R.

Agent Spruson & Ferguson

Pub. Number AU-A-2006316646

PCT Pub. Number WO2007/061696

Priority 60/737,982 18.11.05 US

Filing date 14 November 2006

Wipo publication date 31 May 2007

International Classifications

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

C07D 413/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/061696 Priority application(s): WO2007/061696

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316648-Enhanced deposit control for lubricating oils used under sustained high load conditions

2006316645-Bicyclic spirohydantoin CGRP receptor antagonists